Chemotherapy is set to become better at treating cancer, while also carrying fewer debilitating side effects, thanks to a new ...

Chemotherapy plus local therapy improved overall survival and disease-free survival when compared to local therapy alone.

AVA6000 Phase 1b expansion cohorts enrolling with data targeted for later in 2025AVA6103 IND-enabling studies underway with a Phase 1 trial ...

The H8F trial, conducted by the EORTC and the Groupe D'Etude des Lymphomes de l'Adulte (GELA), compared combined-modality treatment consisting of three cycles of mechlorethamine, oncovin ...

The UK’s health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended brentuximab ...